INTERVENN

Serial Number 88241891
Registration 6548081
700

Registration Progress

Application Filed
Dec 26, 2018
Under Examination
Sep 24, 2019
Approved for Publication
Jul 30, 2019
Published for Opposition
Jul 30, 2019
Registered
Nov 2, 2021

Trademark Image

INTERVENN

Basic Information

Serial Number
88241891
Registration Number
6548081
Filing Date
December 26, 2018
Registration Date
November 2, 2021
Published for Opposition
July 30, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 2, 2021
Registration
Registered
Classes
042 044

Rights Holder

Venn Biosciences Corporation

03
Address
2 Tower Place, 5th Floor, South
San Francisco, CA 94080

Ownership History

Venn Biosciences Corporation

Original Applicant
03
Redwood City, CA

Venn Biosciences Corporation

Owner at Publication
03
San Francisco, CA

Venn Biosciences Corporation

Original Registrant
03
San Francisco, CA

Legal Representation

Attorney
Timothy D. Sitzmann

USPTO Deadlines

Next Deadline
677 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20211102)
Due Date
November 02, 2027
Grace Period Ends
May 02, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

49 events
Date Code Type Description Documents
Nov 2, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 29, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 28, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 30, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 27, 2021 IUAF S USE AMENDMENT FILED Loading...
Aug 30, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 27, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 22, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 22, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 22, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 11, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 11, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 11, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 2, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 2, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 2, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 26, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 24, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 24, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 24, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 22, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 22, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 22, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 22, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 6, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 4, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 4, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 24, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 30, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 30, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 10, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 26, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 25, 2019 ALIE A ASSIGNED TO LIE Loading...
Jun 17, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 17, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 17, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 17, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jun 17, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 13, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 12, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 12, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 21, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 21, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 21, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 17, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 29, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific and medical research services; scientific and medical research services, namely, biomarker and target discovery services for pharmaceutical development; scientific and medical research services, namely, biomarker discovery and target discovery; providing temporary use of on-line nondownloadable software applications for use in computing, studying, diagnosing or screening for diseases and studying biological molecules; chemical analysis, namely, mass spectrometry services; consulting services in the field of biotechnology through the application of mass spectrometry; scientific and technological services, namely, biomarker analysis in the field of mass spectrometry; scientific and technological analyses using mass spectrometry, namely, chemical, biochemical, and biological in the nature of protein and cellular analysis; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics
First Use Anywhere: 20181000
First Use in Commerce: 20190200
Class 044
Testing and reporting for medical biomarker discovery and validation, target discovery and validation, therapeutics design and development, patient profiling, treatment prediction and monitoring, and medical diagnostic and prognostic purposes; medical testing for screening, diagnostic, or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing a website featuring medical information regarding disease risk factors, disease risk factor analysis, and reporting services for medical purposes
First Use Anywhere: 20181000
First Use in Commerce: 20190200

Additional Information

Pseudo Mark
INTERVEIN

Classification

International Classes
042 044